Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...

LONDON (Reuters) - Britain's medicines watchdog said on Friday it had discovered a batch of counterfeit Novo Nordisk insulin pen needles circulating in the country and urged diabetics not to use them.

DERBY >> Griffin Hospital is warning that insulin pens used on more than 3,000 diabetes patients hospitalized there over the past six years may have been misused, exposing the patients to hepatitis B, ...

ATLANTA A company that makes branded and store-brand diabetes care products has expanded the national distribution of a line of click-on pen needles. Can-Am Care announced this week that its Clickfine ...

For diabetes patients, managing blood sugar levels through insulin pens, needles or pumps is a necessary hassle -- but it might be far easier to handle going forward. The US Food and Drug ...

A Superior Court judge in Waterbury, Conn., has certified class action status for a lawsuit against Griffin Hospital regarding the use of multidose insulin pens. The lawsuit, filed by former patients ...

The 1980s saw the launch of the first blood glucose monitors for at-home use. This revolutionized diabetes care, making self-monitoring a standard practice. Advancements continued, with high-tech ...

DUBLIN--(BUSINESS WIRE)--The "Global Insulin Pen Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global insulin pen market is projected to achieve a significant ...

BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...

Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "Pen Needles Company Evaluation" report has been added to ResearchAndMarkets.com's offering. The Pen Needles Companies Quadrant is a comprehensive ...

The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been ...

Purpose: Patient satisfaction, safety and efficacy outcomes, and cost savings with insulin pens versus conventional insulin delivery via vials and syringes in hospitalized patients with diabetes were ...